BEAMSTART Logo

PharmaResearch acquires TuringBio for digital therapeutics

Korea Economic Daily LogoKorea Economic Daily1w ago

PharmaResearch acquires TuringBio for digital therapeutics - Korea Economic Daily

Quick Summary:

Founded in 2020, TuringBio is an AI-based digital healthcare solution company currently developing evidence-based depression digital therapeutics DepRx, a personalized comprehensive psychological counseling platform WeeDool utilizing generative AI, and VitalTracker, which tracks and predicts digital phenotype data necessary for the quantitative diagnosis of mental disorders.

PharmaResearch Co., a South Korean company specializing in regenerative medicine, announced on Wednesday that it acquired TuringBio, an AI-based digital healthcare solution firm.

PharmaResearch aims to secure talent in digital therapeutics (DTx) and integrate AI technology into its aesthetic and medical businesses, enhancing its expertise and capabilities.

More Pictures

PharmaResearch acquires TuringBio for digital therapeutics - Korea Economic Daily (Picture 1)

or

Article Details

Category: Economy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-10 @ 15:17:17 (1 weeks ago)

News Timezone: GMT +8:00

News Source URL: kedglobal.com

Language: English

Article Length: 100 words

Reading Time: 1 minutes read

Sentences: 10 lines

Sentence Length: 10 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Korea Economic Daily

News ID: 21562553

View Article Analysis

About Korea Economic Daily

Korea Economic Daily Logo

Main Topics: Economy

Official Website: kedglobal.com

Update Frequency: 18 posts per day

Year Established: 1964

Headquarters: South Korea

News Last Updated: 5 minutes ago

Coverage Areas: South Korea

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #91

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "PharmaResearch acquires TuringBio for digital therapeutics" has 100 words across 10 sentences, which will take approximately 1 minutes for the average person to read.

Which news outlet covered this story?

The story "PharmaResearch acquires TuringBio for digital therapeutics" was covered 1 weeks ago by Korea Economic Daily, a news publisher based in South Korea.

How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news.

The outlet is headquartered in South Korea and publishes an average of 18 news stories per day.

It's most recent story was published 5 minutes ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #21562553
  • URL: https://beamstart.com/news/pharmaresearch-acquires-turingbio-for-digital-1720

More News from Korea Economic Daily

Latest Jobs

More Economy News

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2024 BEAMSTART. All Rights Reserved.